Technologies Available for Partnering
Our commitment to innovative research spans a wide spectrum of technologies. From uncovering novel therapeutic targets and pioneering precise diagnostics platforms to harnessing the power of artificial intelligence to expedite the pace of discovery, we push the boundaries of what’s possible in the fight against cancer and related disease.
Showing 49-54 of 54
TransTAC: Next-Generation Targeted Protein Degradation Technology
- Investment
- Licensing
RNA Surveillance Tracks Down and Degrades Cancer-Causing Molecules
- Collaboration
- Investment
Highly Potent and Selective CDK8/CDK19 Inhibitors Target Solid Tumors
- Collaboration
- Licensing